Baxter sees strong Q2, raises full-year outlook

Baxter International has posted strong financial results for the second quarter of 2008 and raised its full-year financial outlook.

For the second quarter, Baxter reported net income of $544 million, which is an increase of 26 percent compared to $431 million reported in the second quarter of 2007, and the earnings increased 31 percent compared to earnings last year. 

Net sales for the second quarter amounted to $3.2 billion, up 13 percent from previous year's sales of $2.8 billion, according to the Deerfield, Ill.-based company. Excluding the impact of foreign exchange, sales grew 5 percent.

Baxter said that sales within the U.S. rose 4 percent to $1.24 billion and international sales amounted to $1.95 billion, a growth of 19 percent over the same period last year. However, excluding the impact of foreign exchange, international sales grew only 6 percent.

Based on the company's strong half-yearly performance, Baxter is raising its earnings forecast for fiscal 2008, before any special items, to a range of $3.28 - $3.32 per share from the previous estimate in the range of $3.18 - $3.24 per share. Baxter expects sales growth for the year, excluding foreign exchange impact, of 5 percent to 6 percent to anticipated earnings on revenues of $12.22 billion.

 

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.